Escient Pharmaceuticals is a clinical-stage company based in San Diego, CA, specializing in the development of targeted therapeutics for neurosensory-inflammatory disorders. With a focus on novel cell surface receptors called MRGPRs, they utilize state-of-the-art medicinal chemistry and biological tools to create highly differentiated treatment options for a wide range of diseases.
Driven by a commitment to advancing innovative solutions for underserved disorders worldwide, Escient is dedicated to discovering and developing life-changing medicines for patients. Their lead programs, EP262 and EP547, target neurogenic inflammation and are being evaluated for chronic urticaria, atopic dermatitis, cholestatic pruritus, and other mast cell mediated disorders.
Generated from the website